Buyer perception of business risk is a key determinant of successful medtech M&A, yet many companies fail to appreciate a potential acquirer’s perspective and how it perceives value. We outline the steps that leaders of earlier-stage companies can take to improve their understanding of what prospective acquirers truly want and thus increase the likelihood of a successful transaction.
Published in MedTech Strategist
Authors: Peter Meyer, PhD & Oded Ben-Joseph, PhD, MBA
Abstract:
Investors are motivated by the prospect of a timely return on their investment in the face of perceived risks. Sell-side CEOs attempt to create shareholder value through managing their business to a set of development milestones.
Strong leaders manage their teams to a set of carefully selected milestones that they believe will create value for their shareholders. However, it is the perceptions of the prospective acquirer that will have greater impact since it is their interest that will likely determine the timing and value of the future investor liquidity event. Buyer perception of business risk is a key determinant of overall transaction value, often incorporating complex analytical and emotional components that must be considered. Sell-side CEOs need to understand and judiciously mitigate buyer risk to maximize value for both parties. The savvy medtech leader will establish clear line-of-sight to their final liquidity event by defining their exit options, understanding what prospective acquirers truly want, building to those value inflecting milestones, and sharing their learnings with investors and acquirers alike.
Appoints Paul Ryb Managing Director to Lead Firm’s Expansion BOSTON–(BUSINESS WIRE)-July 8, 2025-Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Paul Ryb has been appointed Managing Director and will lead the firm’s dedicated ophthalmology practice, providing strategic guidance, transactional support, and advisory services to clients […]
Read MoreOutcome Capital Life Science Market Pulse June 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?